Anti-inflammatory functions of purpurogallin in LPS-activated human endothelial cells

BMB Reports

Volumn 45, Issue 3, 2012, Pages 200-205

  Kim, Tae Hoon ^a   Ku, Sae Kwang ^b   Lee, In Chul ^c   Bae, Jong Sup ^d  

^a Department of Herbal Medicinal Pharmacology   (South Korea)

^b Daegu Haany University   (South Korea)

^c Youngdong University   (South Korea)

^d Kyungpook National University   (South Korea)

Author keywords

Barrier integrity; Cell adhesion molecule; LPS; Purpurogallin

Indexed keywords

ANTIINFLAMMATORY AGENT; FUSED ALICYCLIC AROMATIC COMPOUND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PURPUROGALLIN; TUMOR NECROSIS FACTOR ALPHA;

ANTAGONISTS AND INHIBITORS; CELL ADHESION; CELL CULTURE; CELL MOTION; CELL SURVIVAL; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; HUMAN; INFLAMMATION; METABOLISM; STRUCTURE ACTIVITY RELATION;

ANTI-INFLAMMATORY AGENTS; BENZOCYCLOHEPTENES; CELL ADHESION; CELL MOVEMENT; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INFLAMMATION; LIPOPOLYSACCHARIDES; NF-KAPPA B; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84861865524     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.3.200     Document Type: Article

References (32)

1. Hakkert, B. C., Kuijpers, T. W., Leeuwenberg, J. F., van Mourik, J. A. and Roos, D. (1991) Neutrophil and monocyte adherence to and migration across monolayers of cytokine-activated endothelial cells: the contribution of CD18, ELAM-1, and VLA-4. Blood 78, 2721-2726.
2. Albelda, S. M., Smith, C. W. and Ward, P. A. (1994) Adhesion molecules and inflammatory injury. FASEB J. 8, 504-512.
3. Gearing, A. J. and Newman, W. (1993) Circulating adhesion molecules in disease. Immunol Today 14, 506-512.
4. Tedder, T. F., Steeber, D. A., Chen, A. and Engel, P. (1995) The selectins: vascular adhesion molecules. FASEB J. 9, 866-873.
5. Collins, T., Read, M. A., Neish, A. S., Whitley, M. Z., Thanos, D. and Maniatis, T. (1995) Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers. FASEB J. 9, 899-909.
6. Li, H., Cybulsky, M. I., Gimbrone, M. A., Jr. and Libby, P. (1993) Inducible expression of vascular cell adhesion molecule-1 by vascular smooth muscle cells in vitro and within rabbit atheroma. Am. J. Pathol. 143, 1551-1559.
7. Panes, J., Perry, M. and Granger, D. N. (1999) Leukocyteendothelial cell adhesion: avenues for therapeutic intervention. Br. J. Pharmacol. 126, 537-550.
8. Mehta, D. and Malik, A. B. (2006) Signaling mechanisms regulating endothelial permeability. Physiol. Rev. 86, 279-367.
9. Ware, L. B. and Matthay, M. A. (2000) The acute respiratory distress syndrome. N. Engl. J. Med. 342, 1334-1349.
10. Dhillon, S. S., Mahadevan, K., Bandi, V., Zheng, Z., Smith, C. W. and Rumbaut, R. E. (2005) Neutrophils, nitric oxide, and microvascular permeability in severe sepsis. Chest 128, 1706-1712.
11. Abou-Karam, M. and Shier, W. T. (1999) Inhibition of oncogene product enzyme activity as an approach to cancer chemoprevention. Tyrosine-specific protein kinase inhibition by purpurogallin from Quercus sp. nutgall. Phytother Res. 13, 337-340.
12. Barltrop, J. A. and Nicholson, J. S. (1948) The oxidation products of phenols; the structure of purpurogallin. J. Chem. Soc. 2, 116-120.
13. Das, M., Bickers, D. R. and Mukhtar, H. (1984) Plant phenols as in vitro inhibitors of glutathione S-transferase(s). Biochem. Biophys. Res. Commun. 120, 427-433.
14. Zeng, L. H. and Wu, T. W. (1992) Purpurogallin is a more powerful protector of kidney cells than Trolox and allopurinol. Biochem. Cell Biol. 70, 684-690.
15. Veser, J. (1987) Kinetics and inhibition studies of catechol O-methyltransferase from the yeast Candida tropicalis. J. Bacteriol. 169, 3696-3700.
16. Wu, T. W., Zeng, L. H., Wu, J. and Carey, D. (1991) Purpurogallin-a natural and effective hepatoprotector in vitro and in vivo. Biochem. Cell Biol. 69, 747-750.
17. Wu, T. W., Zeng, L. H., Wu, J., Fung, K. P., Weisel, R. D., Hempel, A. and Camerman, N. (1996) Molecular structure and antioxidant specificity of purpurogallin in three types of human cardiovascular cells. Biochem. Pharmacol. 52, 1073-1080.
18. Inamori, Y., Muro, C., Sajima, E., Katagiri, M., Okamoto, Y., Tanaka, H., Sakagami, Y. and Tsujibo, H. (1997) Biological activity of purpurogallin. Biosci. Biotechnol. Biochem. 61, 890-892.
19. Berman, R. S., Frew, J. D. and Martin, W. (1993) Endotoxin-induced arterial endothelial barrier dysfunction assessed by an in vitro model. Br. J. Pharmacol. 110, 1282-1284.
20. Goldblum, S. E., Ding, X., Brann, T. W. and Campbell-Washington, J. (1993) Bacterial lipopolysaccharide induces actin reorganization, intercellular gap formation, and endothelial barrier dysfunction in pulmonary vascular endothelial cells: concurrent F-actin depolymerization and new actin synthesis. J. Cell Physiol. 157, 13-23.
21. Sawa, Y., Sugimoto, Y., Ueki, T., Ishikawa, H., Sato, A., Nagato, T. and Yoshida, S. (2007) Effects of TNF-alpha on leukocyte adhesion molecule expressions in cultured human lymphatic endothelium. J. Histochem. Cytochem. 55, 721-733.
22. Mackay, F., Loetscher, H., Stueber, D., Gehr, G. and Lesslauer, W. (1993) Tumor necrosis factor alpha (TNF-alpha)-induced cell adhesion to human endothelial cells is under dominant control of one TNF receptor type, TNF-R55. J. Exp. Med. 177, 1277-1286.
23. Chen, C., Jamaluddin, M. S., Yan, S., Sheikh-Hamad, D. and Yao, Q. (2008) Human stanniocalcin-1 blocks TNF-alpha-induced monolayer permeability in human coronary artery endothelial cells. Arterioscler. Thromb. Vasc. Biol. 28, 906-912.
24. Chen, B. C., Chou, C. F. and Lin, W. W. (1998) Pyrimidinoceptor-mediated potentiation of inducible nitric-oxide synthase induction in J774 macrophages. Role of intracellular calcium. J. Biol. Chem. 273, 29754-29763.
25. Thompson, J. E., Phillips, R. J., Erdjument-Bromage, H., Tempst, P. and Ghosh, S. (1995) I kappa B-beta regulates the persistent response in a biphasic activation of NF-kappa B. Cell 80, 573-582.
26. Wu, T. W., Wu, J., Carey, D. and Zeng, L. H. (1992) Purpurogallin protects both ventricular myocytes and aortic endothelial cells of rats against oxyradical damage. Biochem. Cell Biol. 70, 803-809.
27. Leirisalo-Repo, M. (1994) The present knowledge of the inflammatory process and the inflammatory mediators. Pharmacol. Toxicol. 75(Suppl 2), 1-3.
28. Dejana, E. (1996) Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis. J. Clin. Invest 98, 1949-1953.
29. Muller, W. A. (2002) Leukocyte-endothelial cell interactions in the inflammatory response. Lab. Invest. 82, 521-533.
30. Bae, J. S. and Rezaie, A. R. (2008) Protease activated receptor 1 (PAR-1) activation by thrombin is protective in human pulmonary artery endothelial cells if endothelial protein C receptor is occupied by its natural ligand. Thromb Haemost 100, 101-109.
31. Akeson, A. L. and Woods, C. W. (1993) A fluorometric assay for the quantitation of cell adherence to endothelial cells. J. Immunol. Methods 163, 181-185.
32. Che, W., Lerner-Marmarosh, N., Huang, Q., Osawa, M., Ohta, S., Yoshizumi, M., Glassman, M., Lee, J. D., Yan, C., Berk, B. C. and Abe, J. (2002) Insulin-like growth factor-1 enhances inflammatory responses in endothelial cells: role of Gab1 and MEKK3 in TNF-alpha-induced c-Jun and NF-kappaB activation and adhesion molecule expression. Circ. Res. 90, 1222-1230.